Amlodipine besylate and atorvastatin calcium (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Amlodipine besylate and atorvastatin calcium drug offered from Mylan Pharmaceuticals Inc.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Amlodipine besylate and atorvastatin calcium |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-06-24 |
| END MARKETING DATE: | 0000-00-00 |
Amlodipine besylate and atorvastatin calcium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amlodipine besylate and atorvastatin calcium from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2014-06-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-4510_f6c7aee9-febe-41e0-b83e-810e46156b28 |
| PRODUCT NDC: | 0378-4510 |
| APPLICATION NUMBER: | ANDA200465 |
Other AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE Pharmaceutical Manufacturers / Labelers:
